# SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA206081** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2023-07-31
## Drug
- **FDA Application Number:** ANDA206081
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Metformin Hydrochloride
- **Active ingredients:** METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SUN PHARM
- **First approval:** 2023-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206081)
---
*AI Analytics · CC0 1.0*